BS

BOB SHEPLER

LOCKHEED MARTIN CORPORATION · Bethesda, MD · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
4
2 agencies contacted
Activity
filings by quarter
Works on

Background

Career
Bethesda, MD
2024 - present

Specific issues

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing
Taxation/Internal Revenue Code · 2024 Q4
HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives to promote economic growth, specifically the immediate deduction of the cost of U.S. based research and investment investments; S 866/HR 2673 - American Innovation and R&D Competitiveness Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures, eliminating the five-year amortization requirement for research and experimental expenditures; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to reform and prescription drug pricing
Taxation/Internal Revenue Code · 2024 Q3
S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related Pharmacy Benefit Manager reform and prescription drug pricing; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to Health Savings Account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to Health Savings Account modernization; HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives for economic growth, improvements for the child tax credit, and eliminate the five-year amortization requirement for research and development; S 866/HR 2673 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures and eliminating the five-year amortization requirement for research and experimental expenditures
Taxation/Internal Revenue Code · 2024 Q2
HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to making improvements to the child tax credit, provide tax incentives to promote economic growth, specifically the provision related to the immediate deduction of the cost of U.S. based research and investment investments; S 866 - American Innovation and Jobs Act including issues related to revising and expanding the deductibility of research and development expenditures to allow for the immediate expensing of such expenditures; HR 2673 - American Innovation and R&D Competitiveness Act of 2023 including issues related to eliminating the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred; HR 5688 - Bipartisan HSA Improvement Act of 2023 including issues related to health savings account modernization; HR 5687 - HSA Modernization Act of 2023 including issues related to health savings account modernization; HR 3561 - PATIENT Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing; S 127 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related to pharmacy benefit manager reform and prescription drug pricing
Taxation/Internal Revenue Code · 2024 Q1

Clients

$██,███ / qtrUnlock

Filing history

2024 Q4
LOCKHEED MARTIN CORPORATION
Q4lda.gov →
2024 Q3
LOCKHEED MARTIN CORPORATION
Q3lda.gov →
2024 Q2
LOCKHEED MARTIN CORPORATION
Q2lda.gov →
2024 Q1
LOCKHEED MARTIN CORPORATION
Q1lda.gov →
Showing recent filings · full history on lda.gov